August 1, 2024

Petoskey man is first in state to receive HEMGENIX gene therapy — 9&10 News

GREEN BAY, WI — Andrew Bartkowiak, a Hemophilia Outreach Center patient from Petoskey, became the first Michigan resident with hemophilia B to receive FDA-approved HEMGENIX gene therapy. His treatment offers new hope for fewer bleeds and freedom from regular infusions.

Read full story on 9&10 News

Recent Posts

Out On The Town: Bleeding Disorders Awareness Edition

In this special episode of Beyond the Bleeds, Heather and John take bleeding disorder awareness beyond the clinic and into the community. From downtown Green Bay to St. Norbert College in De Pere, Wisconsin, they hit the streets to ask everyday people what they know...

Have You Thought About Fiber Lately?

You may have thought about many aspects of your health such as sunscreen, protein, or exercise but one essential nutrient remains grossly underappreciated: dietary fiber. Fiber doesn’t come with flashy marketing or miracle claims, yet its impact on human health is...

Social Media